"Pipecolic Acids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
| Descriptor ID |
D010875
|
| MeSH Number(s) |
D03.066.758 D03.383.621.758
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pipecolic Acids".
Below are MeSH descriptors whose meaning is more specific than "Pipecolic Acids".
This graph shows the total number of publications written about "Pipecolic Acids" by people in this website by year, and whether "Pipecolic Acids" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 2 | 2 | 4 |
| 2020 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Pipecolic Acids" by people in Profiles.
-
Using Nonheparin Anticoagulant to Treat a Near-Fatal Case With Multiple Venous Thrombotic Lesions During ChAdOx1 nCoV-19 Vaccination-Related Vaccine-Induced Immune Thrombotic Thrombocytopenia. Crit Care Med. 2021 09 01; 49(9):e870-e873.
-
SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia treated with immunoglobulin and argatroban. Lancet. 2021 06 26; 397(10293):e19.
-
Autoimmune heparin-induced thrombocytopenia: a rare manifestation of COVID-19. BMJ Case Rep. 2021 May 24; 14(5).
-
Thrombolysis and use of argatroban for the treatment of massive pulmonary embolism following anticoagulation failure in a patient with COVID-19. Am J Health Syst Pharm. 2020 11 16; 77(23):1961-1964.
-
Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study. BMC Nephrol. 2020 11 16; 21(1):486.
-
Emergent Carotid Artery Stenting Following Intravenous Alteplase Infusion After Rapid Negative Diagnosis for COVID-19 by Loop-Mediated Isothermal Amplification Assay. World Neurosurg. 2021 01; 145:356-359.
-
Anticoagulation Strategies and Filter Life in COVID-19 Patients Receiving Continuous Renal Replacement Therapy: A Single-Center Experience. Clin J Am Soc Nephrol. 2020 12 31; 16(1):124-126.
-
Thrombin Inhibition by Argatroban: Potential Therapeutic Benefits in COVID-19. Cardiovasc Drugs Ther. 2021 Apr; 35(2):195-203.
-
Argatroban for therapeutic anticoagulation for heparin resistance associated with Covid-19 infection. J Thromb Thrombolysis. 2021 Jan; 51(1):243-245.
-
Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019. J Thromb Thrombolysis. 2020 Nov; 50(4):1012-1014.